KIMBERLY R MCDONALD

Allopathic & Osteopathic Physicians|Medical Genetics|Clinical Genetics (M.D.) LOUISVILLE, KY NPI 1598077430

General Payments — all program years on this page

$15,483.05

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 76
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $12,637.45 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $10,781.002
Travel and Lodging $1,143.303
Food and Beverage $713.157

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
GENZYME CORPORATION $12,313.468
BioMarin Pharmaceutical Inc. $241.792
UCB, Inc. $63.001
Amicus Therapeutics, Inc. $19.201

By program year

Program yearAmountRecords
2018 $2,452.5441
2019 $255.8216
2020 $35.982
2022 $101.265
2024 $12,637.4512

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1127062224 BioMarin Pharmaceutical Inc. $120.44 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127062634 BioMarin Pharmaceutical Inc. $121.35 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139855411 GENZYME CORPORATION $2,156.00 03/29/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1139855419 GENZYME CORPORATION $71.49 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139855421 GENZYME CORPORATION $113.40 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139855481 GENZYME CORPORATION $204.27 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139855483 GENZYME CORPORATION $300.31 08/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139855485 GENZYME CORPORATION $609.83 08/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139855487 GENZYME CORPORATION $233.16 08/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139855489 GENZYME CORPORATION $8,625.00 08/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1143119404 UCB, Inc. $63.00 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148420663 Amicus Therapeutics, Inc. $19.20 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.